logo
Monetary policy is crucial to manage household inflation expectations, shows RBI study

Monetary policy is crucial to manage household inflation expectations, shows RBI study

The RBI released a study paper in its July bulletin to understand the Indian household inflation expectations. This study uses unit level data on 1-year ahead median inflation expectations from the Reserve Banks Inflation Expectations Survey of Households (IESH), to understand their dynamics post pandemic, key determinants and effectiveness of monetary policy in anchoring these expectations, particularly under the flexible inflation targeting (FIT) regime.
Household inflation expectations are particularly important because households represent the largest and most diverse economic group, directly driving consumption. Unlike professional forecasters, households expectations are often shaped by personal experiences and are susceptible to fluctuations.
Indian household inflation expectations, revealing that they remain elevated compared to those of professionals, even during periods of price stability. Demographic factors such as gender, age, and professional background play significant roles.
Notably, men, older individuals (45 and above), self-employed and daily workers, who often operate on variable incomes, exhibit higher inflation expectations.
In contrast, younger and salaried individuals show less disagreement and are more attuned to realized inflation dynamics, likely reflecting their exposure to financial and social network.
Transition to the FIT regime, along with timely fiscal interventions such as export bans and lower import duties, and moderating inflation levels have contributed to decline in both the levels of expectations and disagreement across responses.
However, supply shocks and global inflation shocks induced by the pandemic and geopolitical tensions have elevated the inflation expectations, particularly across headline, food and housing categories.
High food inflation during periods of high inflation may keep the expectations elevated, even as headline matters more for inflation expectations. Nonetheless, most recently, as inflation has been showing signs of easing, expectations of households have also come down.
Given the evidence of non-rationality and heterogeneity across different groups of households each reflecting their systematic biases the role of monetary policy becomes critical in managing inflation expectations.
This, in turn, underscores the challenges of effective policy communication, making it essential to understand how these expectations are shaped and managed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Indian drugmakers aim to boost exports to Mexico, South America's No. 2 pharma market
Indian drugmakers aim to boost exports to Mexico, South America's No. 2 pharma market

Mint

time29 minutes ago

  • Mint

Indian drugmakers aim to boost exports to Mexico, South America's No. 2 pharma market

New Delhi: Indian drugmakers are in talks with Mexico for a simpler approval process as they seek to boost exports to the second-largest pharma market in South America, said two people aware of the matter. The Indian Drugs Manufacturers Association (IDMA) is intensifying its focus on Mexico, betting that the nation's complex drug approval process will be simplified, the people said on the condition of anonymity. Members of the association are in talks with officials from Mexico's ministry of economy and health regulator COFEPRIS (Federal Commission for the Protection against Sanitary Risks) to explore new rules and financial incentives, the people said. India seeks to significantly boost its medicine exports to Mexico, a market currently valued at over $20 billion and is expected to grow to $38.5 billion by 2033, according to a report by the International Market Analysis Research and Consulting Group. Domestic pharmaceuticals account for only $180 million. Indian drugmakers encounter challenges, primarily the lengthy and intricate regulatory hurdles set by COFEPRIS. India's pharmaceutical industry, the world's third largest by volume, is a global powerhouse with a diverse product base including generic drugs, vaccines, and biologics. In the fiscal year 2023-24, the market was valued at $50 billion, with exports accounting for $26.5 billion, according to the estimates provided by the Department of pharmaceuticals. Queries emailed to the Embassy of Mexico in New Delhi remained unanswered. "IDMA regularly participates in interactions with National Regulatory Agencies from various geographies," said Dr. Viranchi Shah, national spokesperson for IDMA. The talks reflect Mexico's increasing recognition of India as a reliable supplier of high-quality, affordable medicines. This push is part of a broader effort to strengthen the overall trade relationship between the two countries. While India's exports to Mexico have been growing, largely driven by the automobile and auto parts sectors, the pharmaceutical industry remains an underexplored avenue. Indian drug companies are keen to leverage Mexico's proximity to the US and its network of trade agreements to use it as a base for expanding into North and Central American markets. While a recent virtual meeting was postponed, an official familiar with the matter said IDMA is in contact with Mexican authorities to resolve the issues. This follows a similar meeting held a few months ago, indicating a consistent dialogue to streamline processes for Indian drug manufacturers. Mexico's pharmaceutical market, the second largest in Latin Americaafter Brazil and growth is fuelled by an ageing population and a rising prevalence of chronic diseases. For Indian companies, which are global leaders in generic drug production, a simplified regulatory path in Mexico could unlock a major new export corridor and diversify their international presence.

India may impose 3-year tariff on top steel producers, China to feel impact
India may impose 3-year tariff on top steel producers, China to feel impact

Hindustan Times

time29 minutes ago

  • Hindustan Times

India may impose 3-year tariff on top steel producers, China to feel impact

The Indian government may impose a three-year import tariff of 11–12 per cent on some selected steel products, if it heeds to a communique by its Directorate General of Trade Remedies (DGTR) on August 16. The recommendation is aimed at curbing rising shipments from top steel producers like China.(REUTERS) The proposed tariff on steel imports would begin at 12% in the first year, reduce to 11.5% in the second, and further drop to 11% in the third, Reuters reported. The move would curb rising shipments from top steel producers like China, whose oversupply has disrupted global markets. "The Authority concludes that there is a recent, sudden, sharp and significant increase in imports," the DGTR notification said, adding that this could cause serious injury to the domestic steel sector. This latest recommendation follows a temporary 12% safeguard duty imposed by India in April for 200 days after preliminary findings showed a steep increase in steel imports. The final recommendation now formalises the case for longer-term protection. Global steel glut behind tariff push The DGTR also said that due to 50% tariffs on steel imports into the US, coupled with similar measures by other countries, a bulk of steel volumes are lying with manufacturers across the world. "Therefore, the safeguard duty must address, not only the serious injury suffered by the domestic also the threat of serious injury that is likely to arise in the future." Trade tensions on the rise as global steel tariffs tighten The recommendation comes amid a wave of international trade protection against Chinese steel exports. US President Donald Trump's import tariffs on steel have fuelled a wave of trade frictions against Chinese steel, with countries including South Korea and Vietnam imposing anti-dumping levy. In a related move, Japanese steel industry lobby groups have also called for faster action to prevent evasion of anti-dumping duties and protect their domestic markets from unfair imports.

Trump's Official Urges India To Stop Purchases Of Russian Oil For 'Funding' War In Ukraine
Trump's Official Urges India To Stop Purchases Of Russian Oil For 'Funding' War In Ukraine

India.com

time29 minutes ago

  • India.com

Trump's Official Urges India To Stop Purchases Of Russian Oil For 'Funding' War In Ukraine

White House trade adviser Peter Navarro has targeted Indian purchases of Russian crude oil, accusing it of funding Moscow's war in Ukraine and called for New Delhi to stop, Al Jazeera reported, citing the opinion piece published in the Financial Times. In an opinion piece published in the Financial Times on Monday, Navarro wrote, "India acts as a global clearinghouse for Russian oil, converting embargoed crude into high-value exports while giving Moscow the dollars it needs." Notably, US President Donald Trump and his administration have continuously targeted India over its purchase of Russian crude oil. India, on the other hand, has always maintained that India's purchases are based on its domestic needs and economic security. The Ministry of External Affairs also pointed out in its recent statement that the US and European Union purchase much more oil and other goods than India. Further, Navarro slammed India for "cosying up" to Russia and China, saying "if India wants to be treated as a strategic partner of the US, it needs to start acting like one." India's dependence on Russian crude is "opportunistic and deeply corrosive of the world's efforts to isolate Putin's war economy," he added. The adviser also said that it was risky to transfer cutting-edge US military capabilities to India as New Delhi's ties to China and Russia deepen, as per Al Jazeera. Navarro is the second senior Trump administration official to accuse India of financing Russia's war in Ukraine. Stephen Miller, deputy chief of staff at the White House, in the first week of August, said that New Delhi's purchase of Russian crude was "not acceptable". "What he (Trump) said very clearly is that it is not acceptable for India to continue financing this war by purchasing the oil from Russia," Miller, one of Trump's most influential aides, said in an interview to Fox News. In response, the Ministry of External Affairs said that the country is being 'unfairly' singled out for buying Russian oil. At the same time, the US and European Union continue to buy goods from Russia. The EU and US trade much more with Russia than India does, New Delhi's contention for being singled out - although this trade has dipped significantly since Russia invaded Ukraine in February 2022. The EU's total trade with Russia plummeted to USD 77.9 billion in 2024, down from USD 297.4 billion in 2021. Notably, the EU continues to import Russian gas, with expenditures reaching USD 105.6 billion since the war began. This amount is equivalent to approximately 75 per cent of Russia's 2024 military budget, according to the Centre for Research on Energy and Clean Air. In contrast, the total trade between the US and Russia stood at USD 3.5 billion in 2024. US goods exports to Russia in 2024 were USD 528.3 million, down 11.8 per cent (USD 70.5 million) from 2023. Meanwhile, on this 79th Independence Day, Prime Minister Narendra Modi, during his speech, said that, "Modi will stand like a wall against any policy that threatens their interests. India will never compromise when it comes to protecting the interests of our farmers." Notably, at the beginning of this month, United States President Donald Trump imposed 50 per cent tariffs on Indian goods over the issue, straining US-India ties. India and the US have been negotiating for months to finalise a free trade agreement, with Trump accusing New Delhi of denying access to US goods by imposing high tariffs.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store